Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Profile HIT algorithm for Restylane facial fillers
NCT05819502Completed
- Sponsor
- Erevna Innovations
- Start
- Mar 2023
- Primary completion
- Feb 2024
- Modality
- Injectable Hydrogels, Implantable Devices, Implantable Hydrogels
- Countries
- 1
01
Overview
Open-label, single-arm trial of nasha hyaluronic acid, sponsored by Erevna Innovations. Primary endpoint: Global Aesthetics Improvement Scale at 8 weeks. Started Mar 2023; status: completed.
02
Drugs
nasha hyaluronic acid
Beyond the preview
Go deeper on NCT05819502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05819502.